• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

Parmax Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
540359
INE240T01014
-18.3323978
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
31.01
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

corpus ltd
Radico Khaitan consolidated net profit rises 94.92% in the March 2026 quarter
May 06,2026
Net profit of Radico Khaitan rose 94.92% to Rs 179.46 crore in the quarter ended March 2026 as against Rs 92.07 crore during the previous quarter ended March 2025. Sales rose 15.31% to Rs 1503.71 crore in the quarter ended March 2026 as against Rs 1304.08 crore during the previous quarter ended March 2025.

For the full year,net profit rose 74.90% to Rs 604.48 crore in the year ended March 2026 as against Rs 345.61 crore during the previous year ended March 2025. Sales rose 24.72% to Rs 6050.43 crore in the year ended March 2026 as against Rs 4851.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1503.711304.08 15 6050.434851.15 25
OPM %18.9213.61 -16.8813.89 -
PBDT279.22158.85 76 974.81605.18 61
PBT237.02122.87 93 821.78465.04 77
NP179.4692.07 95 604.48345.61 75